This inventor holds 13 USPTO granted patents and 14 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Newmarket Pharmaceuticals LLC, Orcosa Inc.. Active years: 2014-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Princeton, NJ (US) (2014 - 2020)
- Pennington, NJ (US) (2021)
- Skillman, NJ (US) (2021 - 2023)
- Daniel Island, SC (US) (2024)
Company Filing History:
Years Active: 2014-2026
Title: Innovations in Veterinary Pharmaceuticals by Mark Ridall
Introduction
Mark Ridall is a notable inventor based in Princeton, NJ, who has made significant contributions to the field of veterinary pharmaceuticals. With a total of 11 patents to his name, Ridall has focused on developing innovative solutions for animal health.
Latest Patents
One of Ridall's latest patents is for veterinary pharmaceutical compositions designed for direct systemic introduction, commonly referred to as DSI pharmaceutical compositions. This composition includes approximately 10-17 dry mass % bovine gelatin, 10-17 dry mass % mannitol, 0-1 dry mass % of a surfactant, and 65-80 dry mass % of the active pharmaceutical ingredient, which is a proton pump inhibitor. The method of manufacturing this composition involves combining pharmacologically inactive compounds to create a first solution, using surfactants to form a second solution, and then adding the active pharmaceutical ingredient to create a first mixture. This mixture is then combined with the first solution to form a pre-formulation, which is subsequently frozen and lyophilized. Another significant patent involves compositions and methods for treating various conditions in animals, which require administering an effective amount of an immediate release composition containing 0.5% to 50% wt/wt of active ingredient, designed to dissolve rapidly upon administration.
Career Highlights
Throughout his career, Ridall has worked with several companies, including Newmarket Pharmaceuticals LLC and Orcosa Inc. His work has focused on creating effective pharmaceutical solutions that enhance animal health and treatment outcomes.
Collaborations
Ridall has collaborated with notable individuals in the field, including David Rock and Vincent T Mileto, contributing to the advancement of veterinary pharmaceutical innovations.
Conclusion
Mark Ridall's contributions to veterinary pharmaceuticals through his innovative patents and collaborations have significantly impacted animal health. His work continues to pave the way for advancements in veterinary medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile